chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache; Slight arm pain; Fatigue; Grogginess; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO161) via an unspecified route of administration in the left arm on 12Apr2021 at 12:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medication, food or any other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included chorionic gonadotrophin (NOVAREL), arginine (L-ARGININE), fish oil (MANUFACTURER UNKNOWN), ubidecarenone; linum usitatissimum seed oil; conjugated linoleic acid (COQ10) and prenatal (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 12:30, the patient experienced slight arm pain, headache, grogginess and fatigue. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events slight arm pain, headache, grogginess and fatigue was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Mom called 9-30-09 around 11:00, said child at day care and T got to 102 and child had seizure. EMT came to day care. Child OK. Had hx of fever seizures. Mom had been giving TYLENOL and MOTRIN after 9-29-09 shots to keep T down.
Has had them 4 times/ suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Has had them 4 times/ suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 25-MAR-2023 This case was reported by consumer cousin via interactive digital media. The reporter reported that his or her cousin received Singles vaccine still experienced shingles four times. The reporter stated that the vaccine does not help him or her. The reporter also stated that the shingles vaccine did not prevent you form getting shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory details were unknown at a time of reporting. The follow-up could not be possible as the as no contact details were available.
Moderate pain from shoulder to the elbow; This spontaneous case was reported by a patient and describes the occurrence of ARTHRALGIA (Moderate pain from shoulder to the elbow) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Heart disorder (Heart Condition). Concomitant products included MIRABEGRON (MYRBETRIQ), METOPROLOL, CLOPIDOGREL, LOSARTAN, ISOSORBIDE and FINASTERIDE for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced ARTHRALGIA (Moderate pain from shoulder to the elbow). At the time of the report, ARTHRALGIA (Moderate pain from shoulder to the elbow) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.  It was reported that the pain has become very strong during the last 4 - 5 days
Discharge Provider: Private MD Primary Care Physician at Discharge: Private DO  Admission Date: 10/8/2022  Date of Death: 10/13/22 Time of Death:  2:13 AM Preliminary Cause of Death: acute respiratory failure with hypoxia  PRESENTING PROBLEM: Somnolence [R40.0] STEMI (ST elevation myocardial infarction) (HCC) [I21.3] ST elevation myocardial infarction (STEMI), unspecified artery (HCC) [I21.3] COVID [U07.1] Failure to thrive   HOSPITAL COURSE: 87 y.o. female with a history of CAD s/p CABG, recent GIB due to gastric erosions/esophagitis, HTN, HLD, carotid stenosis who presented with weakness and lethargy and found to have ST elevation, elevated troponins concerning for STEMI, in addition to COVID. Patient was not a candidate for catheterization per cardiology and unable to be put on heparin drip due to recent GIB.  On admission, patient initially admitted as comfort care. Given further evaluation, the EKG more likely indicative of NSTEMI or myocarditis (less likely STEMI) based off prior EKG, discussion with patient's daughter to change patient from comfort care to DNR/DNI (on 10/9). Echo showed normal EF 66%. Patient also given one dose remdemisvir and decadron, given her COVID infection.   Discussion with family on 10/10: The family came to the conclusion to move the patient to comfort care status given her overall well being, including her inability to eat, her body mass index, and her other medical comorbidities. Patient was then admitted to general inpatient hospice, and her symptoms were well controlled with scheduled sublingual morphine and ativan. Patient passed away comfortably on the morning of 10/13/22 with daughter at bedside.
temp started late Mon 103.9 was 102.6; seems to have discomfort on legs where shots given; cranky;
Adverse event: Left shoulder pain 1 week after injection administration.  Treatment: Physical therapy Outcome: Unknown
SOB, Diaphoretic, Tachycardia, hypotension, Decreased Heart Rate, Decreased oxygen saturation. PT was taken to the ER.
within 5 min of  receiving the  injection I started to itch really bad, broke out in hives the following day which was Friday, on Saturday  I had a slight fever,  every part of my body hurt and was very fatigued. My arm still hurts.
11 year old with fever of 103 yesterday. Vomiting x 5 yesterday and neck pain since yesterday. Fever and vomiting have resolved but still having neck pain.
Itching and "rash" in the arm area of the vaccination, but then spread to other parts of the body
Moderate Body aches  Arm soreness  Extreme Fatigue Low Pressure on chest
The night after the booster shot, I got fever, joint pain, fatigue, muscle pain and I had to take off from work the next day. The second day after I was still weak and the fever still was and ongoing. I was better on day 3. Then on 12/17/2021 I started my period and it was the worst period of my life. I was bleeding so much, I was bleeding one menstrual cup every 45 mins. I was diagnose low Iron about a year ago, I am schedule for another blood test to see if my Iron level has taken a dive. Then after my period was done, 3 days later I started spotting again. At first it started light and then it progress in me bleeding a menstrual cup every day. An if you have Iron problems that is  very serious. That went on for two weeks. I called my GYN doctor and she referred me to another GYN doctor who specializes in break through bleeding and I am schedule to see her first week of February 2022. The was talking about me having more blood work, Ultrasound and Endometrial Ablation. Am seeing my PCP on January 24, 2022 where I am to get the blood work done there before my second appt with the other GYN doctor.
Getting a flu shot means misery and suffering; Initial information received on 07-Jan-2022 with live follow-up 08-Jan-2022 (processed together) regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves Adult and unknown gender patient who experienced getting a flu shot means misery and suffering while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious event "getting a flu shot means misery and suffering" (emotional distress) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (Getting a flu shot means misery and suffering).  At time of reporting, the outcome was Unknown for the event getting a flu shot means misery and suffering.
Initial report received on 19 December 2007 from another manufacturer, report number not provided.  The initial reporter to this manufacturer had been a health care professional.  A patient (age, gender, and date of birth not provided) had received an injection of tetanus vaccine, manufacturer not provided, and lot number not provided, on an unspecified date.  At an unspecified time post-vaccination, the patient developed shortness of breath and hives.  Recovery status was not reported.  Additional medically relevant information was not provided.
Detected two chicken pox on upper right arm. Later developed another on right forearm and one on lower left back and behind right leg. Also a single lesion in the mouth.
broke out w/mild case of chickenpox on 18AUG p/receiving vax on 14AUG;chicken pox lesions confirmed by pediatrician;
(First of all, I'm not sure the COVID Vaccine caused this)  Approximately 2 1/2 weeks after receiving the J&J single dose vaccine (around 22Jan21) I started to experience light itching on my lower back.  Within a few days the itching spread to my entire back.  By 30Jan21 i saw my primary care physician and a light rash was presenting on my back and chest.  I was prescribed some cetirizine for itching.  By Saturday 3Apr i had a full blown body rash on my chest, back, down my arms and down to my thighs.  My doctor described it as angry red and indicated it appeared to potentially be some type of allergic reaction to a drug.  On this date 13Apr, the rash has subsided but some itching continues.  We are in the process o
Pt developed itching in the upper (L) arm where pt received PREVNAR 13. Pt did not scracth but rubbed the itchy area. The area appeared red (erythema) and swollen. This started the day after vaccination. It appears to be subsiding. Pt will continue to monitor.
Fever, SkinRash, FATIGUE, HEADACHE, CHILLS, FEVER, BODYACHES RESOLVED IN 3 DAYS. 1/17 HIVES ON RIGHT EAR, NECK AND EYEIID RESOLVED IN 4 DAYS. DIZZINESS AND WEAKNESS FOR ONE WEEK Narrative:
Event #1: severe headache right after vaccination. Pressure headache around forehead and nose. ED visit 1/23 for headache. Cat scan head and neck, negative. headache is still ongoing. Event #2: SOB, heart palpation (started 2/10). ED visit twice (2/13,2/14), admitted to hospital. s/s: severe headache, dizziness, weakness of legs and hands, tingling of hands, anxiousness, feeling of warm/cold, hear pa;pation, inability to fall sleep, fatigue, heartburn, No appetite. Diagnosis: POTS. Symptoms are still on going. Event #3: hand tingling, leg and hand weakness, anxiousness started 1/22/21. Still on going.
ACUTE HYPOXEMIC RESPIRATORY FAILURE 7/15/2022 ATRIAL FIBRILLATION, PAROXYSMAL
Mom reports 4-5 hives localized to trunk and armpits. Occurred same day and resolved within 1 day.
Pt. states about 3 months after receiving second Covid vaccine started having shoulder, hip and thigh pain.  Went to several different doctors - orthopedic, PCP and got referred to a rheumatologist.  After several months, finally got diagnosed with polymyalgia rheumatica. States symptoms have improved since being on Prednisone 12.5 mg PO daily. Pt. states sister was also diagnosed with same condition after receiving her Covid Moderna vaccine.
Patient has a history of fainting with vaccines. This was her first COVID vaccine and she was very nervous. She was fine after the shot, then started to have increased anxiety a few minutes later. She was panicking , breathing quickly, crying, and then briefly lost consciousness. I held her up so she did not injury herself. We applied a cold pack to her face/neck and had her lie on the ground with her feet up on a chair after she came to. She waited in the pharmacy for 30 minutes post incident. Patient felt fine and did not require further medical attention.
SM developed redness, swelling pain at anthrax injection site in triceps within 1-2 hours of receiving his vaccine.  Symptoms: Edema at injection site 50-120mm.
Patient stated he was encouraged by friend to call health dept now because his effects after the shot didn't seem normal. He stated appx 50 minutes after shot #1 (4-1-2021), he had c/o of H/A that lasted 1 wk, brain fog for 1 wk, stomach cramps for 2 days & achy x1 wk, sore arm. He stated 90 minutes after 2nd shot (4-23-2021) he had c/o pounding H/A, arm fatigue, feverish off n on for 1 wk, all 4 extremities (hips to toes, shoulders to fingers) went numb for 2 hours & head fog for 2 days. No vaccines prior to covid vaccine. No issues with health history. Advised to call PCP with his complaints of side effects after the covid vaccine to decide about future booster doses, if they are offered in the coming months.
On 6-12-2022, I started having shortness of breath. On 6-13, I noticed a scratchy throat, head congestion, runny nose, a cough and temp of 99.5. On 6-15, I noticed extreme fatigue. On 6-16, I performed a home Covid 19 test with positive results. I called the doctor the same day and they prescribed Paxlovid. I am feeling fine now. I am reporting a breakthru case of Covid.
Upon administering the dose, the vaccine leaked out of the syringe where the needle meets the barrel.
Patient is 88yo old male, received 2nd dose of Pfizer on 4/20/21. Started feeling sick on 5/21/2021, tested positive for covid on 5/21/2021. Potentially exposed at Dialysis Clinic. Admitted to Hospice on 6/3/2021
headache; fever; muscle cramps; This is a spontaneous report received from contactable reporter(s) (Other HCP) for a Pfizer sponsored program (141003).  A 60 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "rheumatoid arthritis", start date: 2016 (ongoing); "chemotherapy", start date: 2018 (unspecified if ongoing); "radiation", start date: 2018 (unspecified if ongoing); "Lymph node removal", start date: 2018 (unspecified if ongoing); "breast cancer", start date: 2018 (unspecified if ongoing); "pulmonary embolism", start date: 2018 (unspecified if ongoing), notes: pulmonary embolism in 2018 and 2019.; "breathing issue", start date: 2011 (unspecified if ongoing), notes: Breathing issue due to lung nodules from 2011; "lung nodules" (unspecified if ongoing); "depression/discouragement" (unspecified if ongoing); "depression/discouragement due to medication (Unspecified) not working" (unspecified if ongoing); "disease progressing" (unspecified if ongoing); "depression/discouragement due to medication (Unspecified) not working" (unspecified if ongoing). Concomitant medication(s) included: XELJANZ taken for rheumatoid arthritis, start date: 2016 (ongoing). The following information was reported: HEADACHE (non-serious), outcome "recovered", described as "headache"; PYREXIA (non-serious), outcome "recovered", described as "fever"; MUSCLE SPASMS (non-serious), outcome "recovered", described as "muscle cramps".  Additional information: Patient reported to holding therapy per MD for 3 days before and after the COVID vaccine. No symptoms due to the missed doses. Experienced headache, fever and muscle cramps from the vaccine, which has since resolved. Forgot to order on time once due to miscounting pills, no missed doses. Strongly worried about the side effects of XELJANZ. Advised to notify MD. Underwent chemotherapy, radiation and lymph node removal for breast cancer in 2018 and pulmonary embolism in 2018 and 2019. Currently no signs of cancer in body. No mention of hospitalization. Prior to start of therapy and progressively worsening: Breathing issue due to lung nodules from 2011, and depression/discouragement due to medication (Unspecified) not working, disease progressing and "feeling that body is failing." Seeing therapist/psychologist.   Follow-up attempts completed. No further information is expected.
soreness at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received Shingrix and had soreness at the injection site. For tolerance of 2nd dose refer case US2020141485. On 22nd July 2020 the patient received a hepatitis A booster vaccine in her right arm. The reporter consent to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020141485:
Breakthrough case admission after 2 vaccines Moderna 3/2/21 lot# 006B21A;  Moderna 4/22/21 lot# 043B21A;
Urticaria, BENADRYL and hydrocortisone cream, unknown outcome at this time.
a patient received her second dose of GARDASIL-9 on 6/24/2019/ The patient took a home pregnancy test (which was positive) on 6/26/2019; No adverse effects were reported in the patient; Information has been received from a medical assistant concerning a female patient of unknown age. The patient's medical history, concurrent condition and concomitant therapy were not reported.  On 24-JUN-2019, the patient received her second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot# R009614, expiration date 30-NOV-2020; strength and dose were unknown) intramuscularly for prophylaxis.       On 26-JUN-2019, the patient took a home pregnancy test, which was positive. No adverse effects were reported in the patient. The last menstrual period (LMP) and the estimated date of delivery (EDD) was not provided (Vaccine exposure during pregnancy). The outcome of pregnant was pending.
Initial and follow-up information has been received from a registered nurse for the pregnancy registry of GARDASIL, concerning an 18 year old female who on 27-FEB-2008 was vaccinated with the first dose of GARDASIL vaccine (Lot # 658556/1060U) (Expiration date 13-APR-2010), 0.5 mL, I.M.  It was noted that on 27-FEB-2008, the patient received MENACTRA.  After vaccination the patient discovered that she was pregnant.  On an unknown date was performed a prenatal blood work with no abnormal results and an ultrasound with negative results.  In follow-up, on 21-NOV-2008, a registered nurse was reporting that the patient experienced nausea and vomiting shortly after receiving the first vaccination on 27-FEB-2008.  At the time of the initial report, the time of gestation was 32 weeks.  Estimated date of delivery was 23-OCT-2008.  In follow-up was also noted that the patient had competed her pregnancy.  The date of delivery was not available.  The patient sought medical attention at the office.  Additional information has been requested.
Next day post vax, the pt developed swelling and soreness in arm. Pt also had nausea and headache which awakened her from her sleep.
Developed testicular pain a few days after the first shot, and waited 1 week to see if it went away. On 03 Feb21, I met with unit medics for consult and to schedule appointment with primary care manager (PCM). On 09 Feb 21, met with PCM who ordered an ultrasound. 10 Feb 21, received ultrasound, and several masses were detected in right testicle. On 11 Feb 21, I had an orchiectomy that confirmed testicular cancer. On 25 Mar 21, received retroperitoneal lymph node dissection to remove enlarged lymph nodes believed to be stemming from testicular cancer. 16 April 21, cancer confirmed in 2 lymph nodes.
and has not received menstrual period since getting first dose; This is a spontaneous report from a contactable consumer or other non hcp from a Pfizer-sponsored program Support. The consumer (Patient) reported that. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single and received second dose via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. The medical history and concomitant medications were not reported. On an unknown date the patient experienced and has not received menstrual period since getting first dose. It was reported that patient has an employee who lost their vaccination card. Patient is fully vaccinated and has not received menstrual period since getting first dose. Thinks it is vaccine related due to no other underlying illness and at a healthy age of menstruation not premenapausal. The outcome of the event was unknown. Follow-up attempts are completed. No further information expected.
BABIES BEING BORN WITH ISSUES AFTER MOTHERS RECEIVE VACCINE; DRUG EXPOSURE IN UTERO; This spontaneous pregnancy report received from a consumer concerned multiple patients. The patient's height and weight were not reported. No past medical history or concurrent conditions were reported.  The patient's parent received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported.  On an unspecified date, the subject experienced babies being born with issues after mothers receive vaccine, and drug exposure in utero. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from drug exposure in utero, and the outcome of babies being born with issues after mothers receive vaccine was not reported. This report was non-serious. This parent/child case is linked to 20210760501.
Information has been received from a RN concerning a 12 month old female who was vaccinated SC with a 0.5mL dose of varicella virus vaccine live. One month after vaccination, the pt developed break through chicken pox with about 10 lesions and a low grade fever. Unspecified medical attention was sought. The adverse event improved at the time of the report, the pt was recovering. A product quality complaint was not involved. Additional information was received from the RN who indicated that the pt was unk. No further information is expected.